{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021396523990656.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/s41388-023-02596-8"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/s41388-023-02596-8.pdf"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/s41388-023-02596-8"}}],"dc:title":[{"@value":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021396523990664","@type":"Researcher","foaf:name":[{"@value":"Junegoo Lee"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990658","@type":"Researcher","foaf:name":[{"@value":"Emily B. Goff"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990670","@type":"Researcher","foaf:name":[{"@value":"Katherine E. Pendleton"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990656","@type":"Researcher","foaf:name":[{"@value":"Mariah J. Berner"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990661","@type":"Researcher","foaf:name":[{"@value":"Mokryun L. Baek"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990669","@type":"Researcher","foaf:name":[{"@value":"Lin Tan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990662","@type":"Researcher","foaf:name":[{"@value":"Tao Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990666","@type":"Researcher","foaf:name":[{"@value":"James P. Barrish"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990660","@type":"Researcher","foaf:name":[{"@value":"Philip L. Lorenzi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990665","@type":"Researcher","foaf:name":[{"@value":"Sara A. Martinez"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990659","@type":"Researcher","foaf:name":[{"@value":"Gloria V. Echeverria"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990667","@type":"Researcher","foaf:name":[{"@value":"Matthew D. Meyer"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990657","@type":"Researcher","foaf:name":[{"@value":"Iqbal Mahmud"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990668","@type":"Researcher","foaf:name":[{"@value":"Bora Lim"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021396523990663","@type":"Researcher","foaf:name":[{"@value":"Weston Porter"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09509232"},{"@type":"EISSN","@value":"14765594"}],"prism:publicationName":[{"@value":"Oncogene"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2023-02-22","prism:volume":"42","prism:number":"14","prism:startingPage":"1117","prism:endingPage":"1131"},"reviewed":"false","dc:rights":["https://www.springernature.com/gp/researchers/text-and-data-mining","https://www.springernature.com/gp/researchers/text-and-data-mining"],"url":[{"@id":"https://www.nature.com/articles/s41388-023-02596-8.pdf"},{"@id":"https://www.nature.com/articles/s41388-023-02596-8"}],"createdAt":"2023-02-22","modifiedAt":"2023-03-30","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360588381046356224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816786735104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/s41388-023-02596-8"},{"@type":"CROSSREF","@value":"10.1016/j.bbadis.2024.167249_references_DOI_PvpOvlmgP3z5ckqdxzjwVhdQ3He"},{"@type":"CROSSREF","@value":"10.1002/cam4.6987_references_DOI_PvpOvlmgP3z5ckqdxzjwVhdQ3He"}]}